Acquired hyperstrogenism of testicular origin without evidence of neoplasia.
D015065:17-Hydroxycorticosteroids / Q000652:urine; D015068:17-Ketosteroids / Q000652:urine; D000311:Adrenal Glands / Q000098:blood supply; D000324:Adrenocorticotropic Hormone; D000328:Adult; D013734:Androgen-Insensitivity Syndrome; D006063:Chorionic Gonadotropin; D004958:Estradiol / Q000097:blood / Q000652:urine; D004964:Estriol / Q000652:urine; D004967:Estrogens / Q000096:biosynthesis / Q000652:urine*; D004970:Estrone / Q000652:urine; D005640:Follicle Stimulating Hormone / Q000097:blood; D006177:Gynecomastia / Q000209:etiology*; D006801:Humans; D007985:Leydig Cells / Q000002:abnormalities; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D008525:Medroxyprogesterone / Q000627:therapeutic use; D008661:Metabolism, Inborn Errors; D011863:Radioimmunoassay; D013733:Testicular Diseases / Q000378:metabolism*; D013736:Testicular Neoplasms; D013737:Testis / Q000098:blood supply; D013739:Testosterone / Q000378:metabolism; D014680:Veins; D014682:Vena Cava, Inferior
D015065:17-Hydroxycorticosteroids; D015068:17-Ketosteroids; D006063:Chorionic Gonadotropin; D004967:Estrogens; D004970:Estrone; D013739:Testosterone; D004958:Estradiol; D000324:Adrenocorticotropic Hormone; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D004964:Estriol; D008525:Medroxyprogesterone